Dr. John Cush RheumNow
4 years 6 months ago
“best laid plans of mice and men oft go astray”.
Dr. Cush giving his opening remarks and pod at #Rnl2022 https://t.co/o9lenN1Dkd
Dr. John Cush RheumNow
4 years 6 months ago
Welcome to #RNL2022 !
Not only are we in-person in Texas, we have people online from all over the US and Canada to New Zealand and Japan!
Dr. John Cush RheumNow
4 years 6 months ago
RheumNow Live is kicking off with a pod on Rheumatoid Arthritis - Future Improvements. Dr. Cush will lead the first presentation on Treatment Choices in Refractory RA. #RNL2022 https://t.co/H3RbDPZxM1
Dr. John Cush RheumNow
4 years 6 months ago
RheumNow Live is HERE. Welcome everyone! What pod are you looking forward to the most?
Anyone out there who is still on the fence--virtual registration is still open. Join us!
https://t.co/3wKgCKqvfD
#RNL2022 https://t.co/W2hUpZ2Y8N
Dr. John Cush RheumNow
4 years 6 months ago
Seropositivity Linked to Bronchiectasis in Rheumatoid Arthritis
Bronchiectasis in rheumatoid arthritis-associated (RA-BR) is uncommon, is unrelated to interstitial lung disease (ILD), but like ILD can substantially impact RA outcomes.
https://t.co/xm8HWJkI5C https://t.co/JztHlzGw65
Dr. John Cush RheumNow
4 years 6 months ago
Disappointment Behind Acute Gout Hospitalizations
https://t.co/Hd1g5Kvwwr https://t.co/jYFVVOQOZX
Dr. John Cush RheumNow
4 years 6 months ago
Environmental Pollutants Ups Autoimmune Disease Risk
An Italian environmental study shows that air pollution increases the risk of autoimmune diseases, in particular rheumatoid arthritis, CTDs and inflammatory bowel diseases (IBD).
https://t.co/LVCn8zgdpG https://t.co/wzi2GzSmGY
Dr. John Cush RheumNow
4 years 6 months ago
Medscapes 2022 Physician Suicide report. Sadly 10% of MDs have considered suicide. Highest in pathology (13%), surgery (12%), oncology (12%), ID (11%), EM(11%). LOWEST in Rheumatology (5%), nephrology (2%) https://t.co/ER8kNfcPEh https://t.co/cWQobpIO97
Dr. John Cush RheumNow
4 years 6 months ago
Happy Match Day to all newly matched doctors! We can't wait to see who becomes a rheumatologist in a few years. Enjoy your residency and celebrate your amazing accomplishment today! https://t.co/Yuhu7ksmog
Dr. John Cush RheumNow
4 years 6 months ago
Among 98 women with axSpA, there were 335 pregnancies & 279 live births - 52% uncomplicated and 48% complicated (13%) multiple complications. axSpA had more Preterm birth (13 vs 5%), pre-eclampsia (7 vs 3%), Low birth Wt (8 vs 3%) https://t.co/i43HKduAgu https://t.co/XHbtH9YMrt
This week we're going to talk about the downside of TNF inhibitors, a few interesting observations in gout, and yes, kids do get COVID. We're also going to preview what's coming in April (hint: it's about PsA). This and more as Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.
Dr. John Cush RheumNow
4 years 6 months ago
Baricitinib has been studied in 15 relapsing GCA pts - prospective, open-label, BARI 4 mg/d w/ GC taper. 14/15 completed 52 wks; 13/15 went into remission and d/c steroids. There was 1 Bari D/C for adverse event & 1 pt w/ serious AE. 1 pt relapsed. https://t.co/J5bjdPAFdm https://t.co/LsuSVP8L0R
Dr. John Cush RheumNow
4 years 6 months ago
Psoriasis RCT studied ADA+MTX (31) vs ADA (30); after 12 mos, a (non-significant) better drug survival w/ ADA-MTX (74 vs 59%; p=0.15). Also favoring, but not signif was PASI 75 (58 vs 37%). Fewer anti-ADA Abs seen w/ ADA-MTX (23 vs 60%; p<0.01) https://t.co/9CAQrpl6hU https://t.co/mr0ZaJ9mbW
Dr. John Cush RheumNow
4 years 6 months ago
Frailty: a decline in the physiologic reserve & function of several systems, leading to increased vulnerability and adverse health outcomes. Not just age; increased in RA (33%) more than AS or PsA. Frailty is dynamic & potentially reversible https://t.co/82hkGKoRxV https://t.co/7d9sycC6S2
